Hester Biosciences Ltd Stock Analysis

BSE: 524669 | NSE: HESTERBIO | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 23-Sep-2022 18:01
1966.50 -70.80 (-3.48%)

DeciZen - Make an Informed Decision on Hester Biosciences

Overall Rating

1. Quality

2. Valuation


3. Price Trend

Hester Biosciences Price Chart

P/E Ratio (SA) :
Market Cap :
1,672.9 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Hester Biosciences Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Hester Biosciences Ltd is a good quality company.

2. Is Hester Biosciences Ltd undervalued or overvalued?

The key valuation ratios of Hester Biosciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Hester Biosciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Hester Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Hester Biosciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Hester Biosciences Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 14.2%14.4%12.9%16.8%18.1%18.3%22.5%14.5%18.5%12.5%-
Value Creation Index 0.00.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 65.169.190101123135171169208219211
YoY Gr. Rt. %-6.1%30.4%12.1%22.2%9.3%27%-1%23.1%5.2%-
Adj EPS 11.411.914.222.829.335.850.935.751.645.438
YoY Gr. Rt. %-4.3%19.3%60.9%28.7%22%42.4%-29.8%44.3%-11.9%-
BVPS (₹) 79.889.399117.9143.5171.7210.9238.7279.3315.5321.4
Adj Net Profit 9.710.11219.424.930.443.330.443.938.632
Cash Flow from Ops. 13.411.420.418.627.632.336.225.841.115.9-
Debt/CF from Ops.


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 14.5%12.2%8.6%5.2%
Adj EPS 16.6%9.2%-3.8%-11.9%
BVPS 16.517.114.413
Share Price 36.7% 13.3% 1.4% -21.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 15.114152122.422.726.615.919.915.311.9
Op. Profit Mgn % 34.436.728.533.433.436.839.731.134.726.724.4
Net Profit Mgn % 14.914.613.419.220.222.625.3182117.615.3
Debt to Equity
Working Cap Days 2672902312292172202082612452810
Cash Conv. Cycle 2002021631601401401341641451660

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 11.90%

Sales growth has been subdued in last 3 years 8.61%

Net Profit has been subdued in last 3 years -3.75%

Sales growth is not so good in last 4 quarters at -6.58%

Latest Financials - Hester Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) 38 36.2
TTM Sales (₹ Cr.) 211 226
BVPS (₹.) 321.4 308
Reserves (₹ Cr.) 265 253
P/BV 6.12 6.42
PE 51.82 54.58
From the Market
52 Week Low / High (₹) 1963.90 / 2851.75
All Time Low / High (₹) 0.25 / 3180.00
Market Cap (₹ Cr.) 1,673
Equity (₹ Cr.) 8.5
Face Value (₹) 10
Industry PE 37.9

Management X-Ray of Hester Biosciences :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Hester Biosciences

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


About Hester Biosciences Ltd

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

The company is a 100% biotech company producing animal biologicals. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art facility to produce live and killed (Inactivated) veterinary vaccines.

Production procedures for poultry vaccines based on in-house advanced capabilities are being followed in the areas of virus propagation in specific pathogen-free embryos, tissue culture, batch fermentation of bacteria, lyophilisation and emulsion preparation.

Hester on December 22, 2008 launched a poultry vaccine against Coryza disease in chicken, containing 3 serotypes – A, B & C.

Hester is the first company in India to manufacture the Coryza vaccine with 3 strains as against other companies manufacturing the vaccine with only 2 serotypes - A & C. Coryza disease is of economical importance to poultry farmers as it causes a drop in egg production in laying birds.

Hester currently manufactures 39 types of poultry vaccines against various poultry diseases.

Product range of the company includes:

  • Live Vaccines
  • Killed Vaccines
  • Diagnostic kits &  Seromonitoring services

Achievements/ recognition:

  • GMP and ISO 9001:2000 certified company
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now